Related Experiment Video
Updated: Aug 12, 2026

08:52
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Vaccines against persistent DNA virus infections
M R Wills1, A J Carmichael, J G P Sissons
1Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
British Medical Bulletin
|August 15, 2002
Summary
Designing vaccines against persistent viruses, like human herpes viruses, is challenging. This research explores strategies for both preventing initial infection and treating established persistent viral infections through postinfective immunization.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Persistent viruses pose unique challenges for vaccine design compared to acute viruses.
- Effective vaccine strategies must address both primary infection prevention and postinfective immunization for established infections.
Purpose of the Study:
- To explore vaccine design challenges posed by persistent viruses.
- To discuss strategies for preventing primary infection by persistent viruses.
- To examine the potential of postinfective immunization for established persistent viral infections, focusing on human herpes viruses.
Main Methods:
- Literature review and synthesis of existing research on persistent DNA viruses.
- Analysis of vaccine design principles for acute versus persistent viral infections.
- Case study focus on human herpes viruses and their implications for vaccine development.
Main Results:
- Persistent viruses require distinct vaccine approaches compared to acute viruses.
- Vaccine goals include primary infection prevention and modifying established infections.
- Human herpes viruses serve as a key example of challenges in persistent virus vaccine design.
Conclusions:
- Vaccine development for persistent viruses necessitates innovative strategies.
- Postinfective immunization is a critical consideration for managing established persistent viral infections.
- Further research into human herpes viruses can inform broader persistent virus vaccine design.
Related Concept Videos
Vaccinations
Overview
Immunological Memory
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

